Literature DB >> 15855582

Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects.

Sophie Bernard1, André Sérusclat, François Targe, Sybil Charrière, Olivier Roth, Jacques Beaune, François Berthezène, Philippe Moulin.   

Abstract

OBJECTIVE: Consensus guidelines recommend cardiovascular risk assessment as the initial step of primary prevention. The aim of this study was to evaluate the incremental predictive value for coronary events conferred by carotid ultrasonography in addition to risk assessment by Framingham score and screening for silent myocardial ischemia in a cohort of type 2 diabetic patients. RESEARCH DESIGN AND METHODS: We prospectively studied 229 patients free of any cardiovascular complication with at least one additional cardiovascular risk factor. At baseline, all patients had an exercise treadmill test, carotid intima-media thickness (IMT) measurement, and coronary risk assessment by Framingham score. Cardiovascular events were registered during a 5-year follow-up period.
RESULTS: Age, carotid IMT, carotid plaques, number of risk factors, Framingham score, and suboptimal exercise electrocardiogram were associated with incident cardiovascular events (P < 0.05). Carotid IMT was an independent predictor of cardiovascular events (P = 0.045). The predictive value for coronary events was similar for carotid IMT and Framingham score as assessed by area under the receiver operating characteristic curves. An improvement in risk prediction was conferred by addition of carotid IMT in a Cox model (global chi(2) increased from 14.1 to 18.1, P = 0.035).
CONCLUSIONS: This prospective study confirms that carotid IMT is a marker of cardiovascular risk in this type 2 diabetic cohort, establishes that carotid IMT provides a similar predictive value for coronary events than Framingham score, and suggests that the combination of these two indexes significantly improves risk prediction for these patients.

Entities:  

Mesh:

Year:  2005        PMID: 15855582     DOI: 10.2337/diacare.28.5.1158

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  27 in total

Review 1.  Cardiovascular risk assessment in type 2 diabetes mellitus.

Authors:  Ebaa Al-Ozairi; R Jan-Willem Middelbeek; Edward S Horton
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

2.  Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Authors:  Theodore Mazzone
Journal:  Circulation       Date:  2010-11-23       Impact factor: 29.690

3.  High HDL cholesterol level after treatment with pitavastatin is an important factor for regression in carotid intima-media thickness.

Authors:  Kenji Okumura; Hideto Tsukamoto; Hideyuki Tsuboi; Haruo Hirayama; Haruo Kamiya; Masato Watarai; Ryoji Ishiki; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2014-01-24       Impact factor: 2.037

4.  Carotid intima-media thickness in Chinese Type 2 diabetic subjects with or without microalbuminuria.

Authors:  C-H Chu; H-C Lam; J-K Lee; C-C Lu; C-C Sun; H-J Cheng; M-C Wang; M-J Chuang
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

Review 5.  Diagnostic and prognostic testing to evaluate coronary artery disease in patients with diabetes mellitus.

Authors:  Neal B Patel; Gary J Balady
Journal:  Rev Endocr Metab Disord       Date:  2010-03       Impact factor: 6.514

Review 6.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Authors:  F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott
Journal:  JAMA       Date:  2008-07-09       Impact factor: 56.272

7.  Myocardial ischemia, carotid, and peripheral arterial disease and their interrelationship in type 2 diabetes patients.

Authors:  Mikael K Poulsen; Jan Erik Henriksen; Jordi Dahl; Allan Johansen; Jacob E Møller; Oke Gerke; Werner Vach; Torben Haghfelt; Henning Beck-Nielsen; Poul Flemming Høilund-Carlsen
Journal:  J Nucl Cardiol       Date:  2009-08-14       Impact factor: 5.952

8.  Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with type 2 diabetes.

Authors:  Kui-Kai Lau; Yuen-Kwun Wong; Yap-Hang Chan; Kai-Hang Yiu; Kay-Cheong Teo; Leonard Sheung-Wai Li; Shu-Leong Ho; Koon-Ho Chan; Chung-Wah Siu; Hung-Fat Tse
Journal:  Cardiovasc Diabetol       Date:  2012-08-18       Impact factor: 9.951

9.  Assessment of carotid atherosclerosis in type 2 diabetes mellitus patients with microalbuminuria by high-frequency ultrasonography.

Authors:  Yu-Hong Zhang; Yuan Gao; Xin Mao; Jing Shang; Ben-Li Su
Journal:  Int J Endocrinol       Date:  2013-03-14       Impact factor: 3.257

Review 10.  Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms.

Authors:  Lei Xiao; Xin Nie; Yanyan Cheng; Nanping Wang
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-17       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.